Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterylab is an Italian medical device manufacturer focused on disposable needles and procedure devices used in biopsy, oncology, gynecology, antenatal diagnostics, interventional radiology, mammography, urology, MRI-guided procedures, and infection control. The company appears to operate as a commercial-stage supplier rather than a therapeutics developer, with a portfolio that includes biopsy needles, bone marrow biopsy and aspiration devices, breast localization products, gynecological instruments, and related consumables. Publicly available sources describe Sterylab as an active, for-profit company with decades of operating history and distribution into international markets, including the United States through Sterylab USA. Based on the available evidence, Sterylab is healthcare-related but not a biotech or drug-development company, and no therapeutic pipeline, molecular targets, or clinical-stage assets were identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterylab.